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1962–2014Yoshiki SasaiYoshiki Sasai was one of the pre-eminent
stem cell biologists. Known as the ‘‘Brain-
maker,’’ he developed methods to guide
human embryonic stem cells (hESCs)
into forming brain cortex, eyes, and other
organs in tissue culture. Yoshiki was a
man of rectitude and a scientist of high
personal integrity, following in the line
of his samurai ancestors. He always
assumed responsibility. Since his post-
doctoral studies, he was called Sensei,
which means teacher, by those that
knew him well. It was an affectionate
sign of the high respect in which this
scholar was held.
In addition to being a prodigiously orig-
inal scientist, Yoshiki was one of the
founding leaders of the RIKEN Center for
Developmental Biology (CDB) in Kobe,
a premier research institute for biology
in Japan. As its Deputy Director, he
embodied the dual nature of the institute,
having both a solid grounding in the em-
bryo and a deep and creative understand-
ing of stem cell differentiation. Yoshiki
played a key role in the initial design of
CDB’s beautiful new laboratories and in
building the smaller adjacent hospital
with the specific purpose of translating
regenerative medicine to the clinic. With
his boundless energy and keen eye for
even obscure regulations, he became an
indispensable person in helping CDB
deal with issues that most other scientists
would have been reluctant to approach.
He was an attentive mentor and one of
the guiding lights of the institute; the stu-
dents who he trained will enrich Japanese
stem cell biology for generations.
A man of strong physique, Yoshiki was
recruited to play the sport he loved, Amer-
ican football, for Kyoto University when he
studied medicine there. Yoshiki was then
a resident at Kobe Municipal General
Hospital. When Kobe was devastated by
an earthquake during his postdoctoral
training in the United States, Yoshiki was
deeply affected by the destruction of this
city he knew so well and would later
greatly contribute to the Japanese gov-
ernment’s efforts to rebuild it. A fully
trained physician, his vocation from thebeginning was focused on understanding
the brain.
HES-1
For his Ph.D. training, Yoshiki joined the
laboratory of molecular biologist Shige-
tada Nakanishi. His Ph.D. thesis work
resulted in the cloning of a mammalian
helix-loop-helix (HLH) transcription factor
in the brain, HES-1. This discovery was
a major contribution to cell signaling
because HES-1 eventually proved to be
the main transcription factor regulated
by the Notch-signaling pathway.
His interest in brain formation prompted
Yoshiki, still as a graduate student, to
write to me in regards to a postdoctoral
research position. We had just isolated a
homeobox gene, goosecoid, expressed
in Spemann’s organizer, the region that
induces the neural plate in Xenopus. Dur-
ing a brief visit to Japan, I interviewed him
in the office of Professor Masatoshi Take-
ichi in Kyoto and recruited one of the
best postdoctoral fellows one could ever
hope for. He promptly secured a Human
Frontiers Science Program fellowship
and came to California in 1993.
Chordin
Yoshiki was a master molecular biologist.
I proposed a differential screen betweenCell 158, Sepdorsal and ventral embryo mRNAs. He
suggested that it would be much easier
to screen for genes increased by lithium
chloride, which expands the Spemann
organizer by inhibiting GSK3, versus em-
bryos ventralized by ultraviolet light in
which the organizer does not form. Within
a month of arrival, he had cloned a new
cDNA, expressed in the gastrula orga-
nizer and later in the notochord, that he
named chordin.
This prompt achievement was per-
formed in spite of a trying introduction to
the USA. In the San Francisco airport, as
Yoshiki was retrieving his luggage, a per-
son approached his wife asking for direc-
tions. While holding her baby, she pointed
to the directions while an envelope con-
taining their passports and a few thou-
sand dollars was being stolen from her
baggage cart. Thus, while immigrating
into a new country, starting a new job,
finding an apartment, and cloning an
important gene, Yoshiki was shuttling
back and forth to the Japanese consulate
to obtain new passports. When I asked
him some time later how the United States
compared to Japan, he responded that it
was like Through the Looking Glass, the
Lewis Carroll sequel to Alice in Wonder-
land. By this, he meant that everything
seemed like the mirror image of what
one might expect. While deeply rooted in
Japanese culture, he did enjoy California
and was a gregarious sushi and barbecue
cook. Celebrations featuring these meals
usually ended up in a hot tub. After his
return, he would introduce many visitors
to the marvelous traditional Japanese
hot spring baths.
The first chordin cDNA was a partial
clone lacking the carboxy-terminal half,
but we had not realized this. We per-
formed hundreds of mRNA microinjec-
tions into Xenopus embryos, but no
phenotype was obtained. One day, Yosh-
iki came and said he had rescreened the
library and had obtained a full-length
mRNA and asked if I would like to micro-
inject it. He was always thoughtful and
respectful in the unique Japanese way.
He gave his mentor the opportunity to
perform the first experiment showing
that chordin induced twinning in Xenopus
embryos.
Chordin encoded a secreted protein
with motifs later found to encode
BMP-binding modules. The sequence,tember 11, 2014 ª2014 Elsevier Inc. 1233
expression pattern, and twinning pheno-
type allowed us to write a paper that
Ben Lewin, the founding editor of Cell,
promptly accepted.
Yoshiki next turned to his initial love
of neural induction using ectodermal ex-
plants of Xenopus embryos. Two other
secreted molecules, Noggin and Follista-
tin, discovered by Richard Harland and
Douglas Melton, had been previously
shown to induce neural tissue. Like
them, chordin induced anterior brain dif-
ferentiation. Herbert Steinbeisser in our
lab was working on BMP4, a TGF-b
growth factor expressed in the opposite
side (ventral) of the embryo. Brain induc-
tion by chordin and noggin mRNA was
antagonized by BMP4 mRNA. As we
were writing the paper, Yoshiki mentioned
in passing that he had also prepared
by PCR a follistatin clone. He gave me
some mRNA to inject, and sure enough
it too was antagonized by BMP4, though
at the time Follistatin was thought to
be exclusively an activin inhibitor. So we
added an extra panel to our manuscript,
showing this last-minute result. Yoshiki
was a very meticulous scientist and
thought that something might be wrong
with his follistatin clone. So without telling
me, he grew up plasmid from three other
cloned colonies over the weekend, syn-
thesized mRNA, injected it, and obtained
the same result. Only then was he satis-
fied, and we submitted the paper to
Nature. This exemplifies how careful he
was to crosscheck others’ experiments,
including my own.
This 1995 Nature letter was the start of
the realization that Spemann’s organizer
secretes a cocktail of BMP antagonists
that are responsible for the formation of
the neural plate in the embryo. There is
another anecdote associated with this
work. After we had written the paper
together, Yoshiki accidentally erased the
entire manuscript file while I was out of
town. He asked my secretary not to tell
and rewrote the entire manuscript from
memory. I only realized this when I found
one or two words that had changed from
the original. He had an amazing photo-
graphic memory.
The purification of chordin protein from
baculovirus constructed by Yoshiki was
left in the hands of Stefano Piccolo. I
found an old note of Yoshiki saying that
‘‘Stefano is a hardworking guy and is get-1234 Cell 158, September 11, 2014 ª2014 Elting accustomed to the project slowly but
steadily. As he is nervous about pressure,
please give him only mild one if neces-
sary.’’ A kind-hearted man, Yoshiki felt
it was his duty to look after everyone in
the laboratory. This collaboration proved
most productive and led to the finding
that chordin was a BMP-binding protein.
Early Neural Target Genes in
Xenopus
In 1996, Yoshiki returned to Japan to
become an associate professor at the
Kyoto University School of Medicine
and was promoted to full professor in
1998. Together with other developmental
biologists, he convinced the Japanese
government to build a new institute for
developmental and regenerative biology
and persuaded Masatoshi Takeichi to
become Director of this new initiative.
Now established in his own lab, Yoshiki
trained a group of very talented students
and began investigating the genes acting
downstream of chordin to mediate the
formation of the central nervous system.
They discovered three early neural genes
induced by chordin and suppressed
by BMP4—Zic1, Sox2, and SoxD—which
were required for neural differentiation.
From his work in Xenopus, Yoshiki
derived a unique feel for neural differenti-
ation that led to his spectacular contribu-
tions to the mammalian stem cell field.
PA6 Cells Induce Dopaminergic
Neurons
Mouse ESCs can differentiate into many
cell types, and traditionally this was
analyzed by preventing their attachment
to substrate in thepresence of high serum,
which leads to the formation of embryoid
bodies consisting of ectoderm, meso-
derm, and endoderm. Yoshiki realized
that itwas critical to beable todifferentiate
ESCs in the complete absence of serum.
He approached this problem by plating
dissociated mESCs on feeder layers of a
large number of cultured cell lines.
The breakthrough came with the dis-
covery that the mouse calvaria PA6 bone
marrow stromal cell line induced efficient
neuronal differentiation. The resulting
neurons were mostly dopaminergic and
were able to improve symptoms of Parki-
sonism when transplanted into mouse
brain basal ganglia. This stromal-cell-
derived inducing activity was located onsevier Inc.the cell surfaceof PA6cells andwasactive
even in formaldehyde-fixed cells. The
gene responsible for this inducing activity
has not yet been cloned. In addition to
dopaminergic cells, some cultures devel-
oped large patches of confluent melanin-
containing retinal pigmented epithelium
(RPE). This observation would lead to
Yoshiki’s revolutionary investigations into
eye development in vitro.
Keeping hESCs Alive
Human ESCs mimic the embryonic
epiblast epithelium. When hESCs are
dissociated, cadherins are released from
the cytoskeleton, causing an activation
of the Rho small GTPase that, in turn, acti-
vates the Rho-associated kinase (ROCK).
The ROCK activation triggers myosin
hyperactivation, blebbing, and apoptosis
via mitochondria. Yoshiki and colleagues
discovered that the simple addition of
the ROCK inhibitor Y-27632was sufficient
to prevent death of dissociated hESCs.
This opened the door for the clonal expan-
sion and differentiation of hESCs, which
they went on to exploit fully in order to
differentiate the human brain in vitro.
Making Brains
Realizing that it was necessary to mini-
mize signals from neighboring cells before
triggering the intrinsic brain differentiation
program, Yoshiki and colleagues devel-
oped a culture procedure in which human
or mouse ESCs are dissociated into sin-
gle cells, allowed to re-aggregate in the
absence of serum, and then directed
to specific differentiation pathways. The
cultured floating ESC aggregates devel-
oped into neuroepithelial vesicles that
were then cultured further to allow for
the expression of their intrinsic self-dif-
ferentiation programs. According to the
initial treatment, the vesicles would
generate various neural organs, such as
telencephalic cortex. The neuron precur-
sors could be transplanted into mouse
brains, where they survived and estab-
lished synaptic contacts corresponding,
for example, to typical pyramidal neurons.
In his most recent article, Yoshiki was
able to grow highly sophisticated human
brain cortex structures. The brain cortex
formed multilayered neuronal structures
in a similar arrangement as that seen in
human fetal cortex at the beginning of
the second trimester. The potential of
these self-organizing forebrain tissues for
the study of human embryonic develop-
ment is enormous.
Making Eyes
The result that stunned the stem cell world
was obtained in 2011, when Yoshiki and
colleagues discovered that their brain
vesicles self-organized into retina and
eyes. They used a mESC line with a retina
homeobox (Rx) GFP knockin to find that
strongly fluorescent patches developed
within the neuroepithelial vesicles. When
the Rx-GFP tissues were excised with for-
ceps from larger aggregates, these frag-
ments were able to recapitulate normal
eye morphogenesis, invaginating to form
an eye cup consisting of a retina including
all of the correct neuronal cell types and
layers covered on the outside by RPE.
On occasion, eye lenses developed.
Similar results were then obtained with
hESCs. This galvanized the regenerative
medicine world because the eye, like
the brain, is an immune-privileged region
and is very suitable for transplantation.
Photoreceptor precursors and RPE cellshave a great and immediate potential for
use in stem cell therapy to cure major
causes of blindness such as retinitis pig-
mentosa and macular degeneration.
Making Pituitary Glands
Another striking demonstration of the
power of stem cells, if allowed to follow
their biological destiny, was the genera-
tion of anterior pituitary. Yoshiki and col-
leagueswere able to obtain fully differenti-
ated pituitary glands secreting multiple
hormones from ESCs in culture. When
transplanted into the brain of mice, these
ESC-derived organs were able to func-
tion and alleviate hypopituitarism. ESCs
contain the regulatory gene networks that
allow them to self-organize, and Yoshiki
realized that all that was necessary was
only to point them in the right direction in
the right culture condition and then allow
them to develop their genetic programs
and cell-cell interactions on their own.
A Brilliant Scholar
This remarkable body of work, in which
the differentiation of entire organs forCell 158, Septransplantation therapy was achieved,
was based on a profound knowledge
of developmental biology. In the 1940s,
Holtfreter and Barth had found that, in sal-
amanders, animal cap ectoderm could in
some conditions self-organize into brain
vesicles, eyes, lens, and olfactory placo-
des. To achieve this in human stem cells,
Yoshiki Sasai had to develop new
methods to keep alive dissociated ESCs,
to re-aggregate them in the absence of
growth factors, and then to allow cells
to interact with each other to elicit the
genetic programs of organogenesis.
HES-1, chordin, and self-differentiation
of organs from stem cells were all remark-
able achievements that opened entirely
new fields of research. One of the leading
lights of Japanese stem cell science is
now extinguished. He is survived by his
wife, daughter, and son. His teachings
will be continued by his many students
and the magnificent RIKEN CDB institute
that he tirelessly built. His passing rep-
resents a great loss to science. He was
only 52.
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